✨ Free AI Report
Arcus Biosciences, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Arcus Biosciences, Inc.
Research Preview

Arcus Biosciences, Inc.: Business Overview, Financials & Competitive Analysis

Arcus Biosciences is a clinical-stage biopharmaceutical company that develops and commercializes cancer therapies in the United States. The company's strategic focus is on targeting well-understood biological pathways...

Analyst-debate audio for Arcus Biosciences, Inc.

AskCyborg analysts argue the bull and bear cases for Arcus Biosciences, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Arcus Biosciences, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Arcus is a focused immuno-oncology player with differentiated ATP-adenosine pathway expertise and multiple Phase 3 programs...

Read the full analyst-debate transcript →
Industry Biopharmaceutical - Immuno-oncology & Cancer Therapeutics
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Arcus Biosciences, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Arcus Biosciences, Inc. Overview

Pro stress-test →

Arcus Biosciences is a clinical-stage biopharmaceutical company that develops and commercializes cancer therapies in the United States. The company's strategic focus is on targeting well-understood biological pathways where there is a significant opportunity to create novel therapies with improved safety and efficacy profiles, leveraging scientific expertise to design best-in-class molecules and combination therapies.

Strategic Profile

Pro stress-test →

Arcus focuses on the ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment, to create and optimize differentiated small-molecule immuno-oncology product candidates. The company's main offerings include development of potential cancer therapies, with particular emphasis on creating combination treatments. 2026 company priorities include rapid enrollment in the PEAK-1 Phase 3 study and initiating a first-line Phase 3 trial in kidney cancer.

Competitive Landscape

Pro stress-test →

Top competitors include Gritstone Bio, Sorrento Therapeutics, Iovance Biotherapeutics, and Avid Bioservices. Arcus differentiates through focused ATP-adenosine pathway expertise and emphasis on combination therapies to address immunosuppression in tumor microenvironment.

Industry Context

Arcus Biosciences, Inc. operates in Biopharmaceutical - Immuno-oncology & Cancer Therapeutics.

Key facts

Founded: 2015 · Headquarters: Hayward, California · Revenue: $240M · Market cap: $2.5B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Arcus Biosciences, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Arcus Biosciences, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Immuno-oncology programsCell therapy and personalized neoantigen approaches→Therapeutic pipelineDiversified biopharmaceutical development→Cell therapy approachTIL cell therapy for solid tumors→

Compare Arcus Biosciences, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Arcus Biosciences, Inc. operates in Biopharmaceutical - Immuno-oncology & Cancer Therapeutics. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceutical - Immuno-oncology & Cancer Therapeutics research →
NEW · MCP server

Ask your AI assistant about Arcus Biosciences, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Arcus Biosciences, Inc. and its top competitor on Cyborg Score”
“What did Arcus Biosciences, Inc. do this quarter?”
“Is Arcus Biosciences, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Arcus Biosciences, Inc. do?+
Arcus Biosciences is a clinical-stage biopharmaceutical company that develops and commercializes cancer therapies in the United States. The company's strategic focus is on targeting well-understood biological pathways...
What is Arcus Biosciences, Inc.'s Cyborg Score?+
Arcus Biosciences, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Arcus Biosciences, Inc.'s main competitors?+
Named competitors include Immuno-oncology programs, Therapeutic pipeline, Cell therapy approach. The full competitive landscape is in the AskCyborg report.
How can I get the full Arcus Biosciences, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Arcus Biosciences, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Arcus Biosciences, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.